Bio App

Pohang, South Korea · Founded 2011 · Privately Held (backing)

Operator of a biotechnology company intended to offer a plant-derived genetically modified subunit vaccine for the prevention of swine fever. Bio App is based in Pohang, South Korea and was founded in 2011. Its last reported valuation was $87.3 million in Jul 2022. It has raised $3.8 million.

Last reported valuation
$87.3M
Oct 2026
Priced at
—
Total raised
$3.8M
Last round
—

Who backs Bio App?

9 investors
InvestorType
Posco InvestmentVenture capital
EcoPro PartnersVenture capital
BNK Venture Capital—
CKD Venture Capital—
DT & Investment—
Daekyo Investment—
ECRUX Venture Partners—
Hanmi Science—
Wonik Investment Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Bio App investors

9 investors are on record for Bio App, including Posco Investment, EcoPro Partners, BNK Venture Capital and CKD Venture Capital.

Free account
More of Bio App with a free account
  • ·Watch Bio App: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Bio App. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View